Genetic Testing for Hypertrophic Cardiomyopathy: Should Your Family Get Screened?

Hypertrophic cardiomyopathy (HCM), is a very common genetic heart disease, often forgotten until a family history, troubling symptoms, or even sudden cardiac death or collapse reveal that HCM is a possibility.

Over one in five individuals in the United States has it. A family history of hypertrophic cardiomyopathy might heighten your anxiety. You can wonder whether the disease is silently developing and putting you at risk for something serious.

If one of your first-degree relatives (like parent, sibling, child) has been diagnosed with hypertrophic cardiomyopathy, you have a 50% chance of having the gene mutation that causes hypertrophic cardiomyopathy.

Genetic mutations can cause thickening of the heart muscle, which impairs the heart’s ability to pump blood effectively. It can increase the risk of life-threatening arrhythmias or a sudden cardiac death.

A simple test can detect HCM-related genetic alterations. Early detection, lifestyle adjustments, and preventative health are possible. This article explains HCM genetic testing, who should consider it, and what families need to know to make informed, long-term, and heart-healthy decisions.

Read More: 10 Causes of Irregular Heartbeat

Understanding Hypertrophic Cardiomyopathy

In hypertrophic cardiomyopathy (HCM), the heart muscle becomes thickened, or hypertrophied. The thicker heart muscle may hamper the heart’s ability to pump blood.

Many individuals with hypertrophic cardiomyopathy are unaware that they have the condition. It is because their symptoms are minimal, if they exist at all. However, the thicker heart muscle can produce severe symptoms in a tiny percentage of HCM patients. These consist of chest discomfort and dyspnea.

Certain HCM patients may experience alterations in the heart’s electrical system. These alterations may cause abrupt death or potentially fatal irregular heartbeats.

Chronic and progressive, HCM can worsen with time, increasing your risk of atrial fibrillation, stroke, heart failure, and sudden cardiac death, as well as causing significant difficulties that limit your ability to perform the things you enjoy.

Research demonstrates that with proper current management, HCM can be fully compatible with a normal lifespan and a standard quality of life.

The Role of Genetics in HCM

A genetic alteration passed down through generations may cause HCM. Genetic testing searches your DNA for these alterations, sometimes referred to as variants.

Genetic testing can alter the medical care you or your family member receives and is helpful in many areas of medicine. Early detection of HCM can help guide and educate the monitoring of your at-risk family members and is crucial for any therapy you may require.

You can learn more about the potential effect of genetic diseases on you or your family members through genetic counseling. The genetic counselor will explain the procedure, possible outcomes, and the associated risks and uncertainties of the test.

Following genetic testing, counseling is also essential so that the counselor can explain the findings and any possible repercussions for your health as well as the health of your family members, including your children.

Patients can also receive help and guidance from genetic counselors regarding how to inform other family members about any genetic variations they may find. However, privacy rules prevent healthcare providers from directly sharing information with family members.

Furthermore, says Johns Hopkins pediatric cardiologist Anne Murphy, “because about 50 percent of children who have a parent diagnosed with HCM also develop the disease, any pediatric patient who faints or develops significant chest pain during exercise, has an abnormal ECG with signs of significant hypertrophy or clearly abnormal T wave changes, or has a family history of HCM should be thoroughly evaluated”.

Read More: How to Strengthen Your Arteries Naturally: What Doctors Suggest for Better Heart Health

What Is Genetic Testing for HCM?

The most prevalent hereditary cardiac disease is HCM. It might be the most common cause of cardiac arrest-related deaths among young people and athletes in the US. Nevertheless, HCM-induced abrupt cardiac arrest is uncommon.

A crucial tool for identifying genetic variants that may cause HCM is genetic testing. A medical practitioner takes a sample of blood or saliva and sends it to a laboratory for testing, a straightforward and noninvasive process.

After that, lab professionals will search for 30 to 50 genes that may be associated with HCM in the sample. By comparing the genes in a person’s sample with a database containing samples from individuals with and without HCM, technicians identify genetic alterations, also known as mutations.

Laboratories typically provide results within three months of receiving the sample.

Who Should Consider Family Screening?

Since HCM frequently exhibits no symptoms, genetic testing is crucial.

Doctors recommend genetic testing for HCM to individuals with a known family history of the disorder. It isn’t always evident, though. An unexpected death from a cardiac episode could be the first indication of HCM in a family.

Following the unexpected passing of a family member

After a sudden death, post-mortem genetic testing is accessible. By enabling medical providers to undertake the following, this testing can assist with family care:

• Assign the cause of death to HCM.
• Determine which gene changes might be the cause of HCM.

Before Getting Pregnant

HCM testing may also help individuals trying to conceive.

To develop, HCM needs one copy of the gene variant. Experts refer to this form of inheritance as autosomal dominant. It means that if one biological parent carries a genetic variant linked to HCM, they can still pass the gene to the offspring.

Although it is uncommon, some people may decide to get tested for HCM during pregnancy. The prenatal test has a significant risk of consequences, and it is impossible to anticipate when symptoms may appear. These factors make doctors less likely to suggest this kind of testing.

Read More: 10 Morning Habits Cardiologists Recommend for a Healthier Heart

Benefits of Genetic Testing

Families receive numerous advantages from obtaining HCM DNA testing; these advantages greatly surpass the ability to confirm a simple diagnosis.

• One of the primary advantages is the ability to identify individuals through genetic testing, as well as the opportunity for early detection. Based on this information, physicians can recommend preventive medicine, lifestyle changes, or continue to monitor the patient over time.
• Preventive medicine can mitigate the risk of future events associated with genetic mutation, even in the absence of clinical symptoms.
• A negative test result provides family members with reassurance, as it indicates they do not carry the genetic variant associated with hypertrophic cardiomyopathy. This allows them to live without concern about developing the condition or requiring unnecessary cardiac screening when genetic evidence suggests the risk is low
• However, genetic testing also allows for personalized management in patients who carry a mutation. Doctors evaluate symptoms, family history, genetic testing results, and other nuances, and personalize treatment plans based on the risk factors revealed by the data.

Limitations and Risks of Testing

Although there are many advantages to genetic testing for hypertrophic cardiomyopathy, families should be aware of the dangers and limits.

Physical risks associated with genetic testing are generally low. Tests using cheek swabs and blood pose virtually no danger. However, there is a little chance of miscarriage with prenatal tests such as chorionic villus sampling or amniocentesis.

Genetic testing may also raise concerns about emotional, social, and financial implications. Before getting a genetic test, talk to your doctor, or a medical geneticist, or to a genetic counselor about all the advantages and disadvantages of the procedure.

What Happens After a Positive Test?

A positive genetic test result for hypertrophic cardiomyopathy (HCM) typically does not indicate an ongoing serious heart condition, but it does warrant more regular surveillance of the patient’s heart health.

Doctors usually advise patients to undergo regular heart assessments, such as echocardiograms, electrocardiograms (ECGs), or cardiac MRIs. A positive result does not change this recommendation. These assessments help doctors track how the heart’s anatomy and function change over time.

Lifestyle changes are significant as well. Patients may receive specific exercise recommendations, typically including a recommendation to avoid competitive sports or intensive activities that may be problematic. Instead, low- to moderate-intensity exercises are recommended for maintaining general health.

Conclusion

Hypertrophic cardiomyopathy (HCM) is the most prevalent inherited heart condition, which is serious. Active screening and genetic testing enable family members to stay one step ahead and treat the condition timely.

Early identification and aggressive treatment of the condition earlier is likely to decrease the likelihood of significant adverse outcomes. These studies also demonstrate that families can promote lifestyle changes, encourage routine monitoring or increased surveillance, and utilize genetic testing to guide targeted therapy for the condition.

The primary lesson here is that DNA testing provides families with answers. DNA tests offer individuals the ability to make informed health and lifestyle decisions, knowing who has the genetic mutation and who doesn’t. For individuals who test negative for the genetic mutation, doctors no longer need to escalate medical procedures, and there is no further concern.

Read More: Heart Health in Your 30s: 8 Habits That Can Protect You for Life

FAQs

Does insurance cover genetic testing?

The amount of insurance coverage for genetic tests for hypertrophic cardiomyopathy (HCM) varies widely by plan, state, and the particular patient.

At what age should children be tested?

Recent clinical guidance from central cardiology authorities suggests that children typically undergo HCM screening between 10 and 12 years of age; however, children with certain risk factors should undergo screening at 10 years of age or younger, and in some cases, even earlier.

How accurate is HCM genetic testing?

Current multigene panels, depending on factors such as a family history of HCM, can typically identify a causal gene mutation in 30% to 60% of patients, suggesting that treatment of HCM with genetic testing has a reasonable level of sensitivity.

Can lifestyle prevent HCM, even with a positive family history?

Lifestyle changes alone cannot prevent hypertrophic cardiomyopathy (HCM) in genetically predisposed individuals, but this can certainly help manage symptoms and slow disease progression.